How Do You Spell NEWBORN HEMOLYTIC DISEASES?

Pronunciation: [njˈuːbɔːn hˌiːməlˈɪtɪk dɪzˈiːzɪz] (IPA)

Newborn Hemolytic Diseases is a medical term used to describe conditions that occur when a mother's blood group is incompatible with that of her newborn. In IPA phonetic transcription, the word is pronounced /ˈnjuːˌbɔːrn ˌhɛməˈlɪtɪk dɪˈziːzɪz/. The term "hemolytic" refers to the breakdown of red blood cells, which can lead to anemia and jaundice in newborns. Treatment usually involves blood transfusions and phototherapy to manage symptoms. Early detection and intervention can improve outcomes and prevent long-term complications.

NEWBORN HEMOLYTIC DISEASES Meaning and Definition

1. Newborn hemolytic diseases, also known as neonatal alloimmune hemolytic diseases, are a group of conditions characterized by the destruction of red blood cells (hemolysis) in newborn babies. These diseases occur when there is an incompatibility between the blood types of the mother and the baby, leading to the production of antibodies in the mother's blood that attack the baby's red blood cells.

   The most common cause of newborn hemolytic diseases is Rh incompatibility, which occurs when the mother is Rh-negative and the baby is Rh-positive. Other blood group incompatibilities, such as ABO or other minor blood group antigens, can also cause these diseases. When the mother's antibodies cross the placenta and attack the baby's red blood cells, it can result in severe complications, including anemia, jaundice, and potentially life-threatening conditions.

   Newborn hemolytic diseases can be diagnosed through blood tests that detect the presence of maternal antibodies in the baby's blood or confirm the destruction of red blood cells. Treatment for these conditions may include blood transfusions, phototherapy to treat jaundice, and medications to manage complications.

   Prevention of newborn hemolytic diseases is possible through the administration of Rh immune globulin (RhIg) to Rh-negative women during pregnancy and after delivery. This medication prevents the production of antibodies that can harm future pregnancies. Early detection and treatment of newborn hemolytic diseases are crucial in minimizing complications and ensuring the well-being of the affected newborn.

Common Misspellings for NEWBORN HEMOLYTIC DISEASES

• bewborn hemolytic diseases
• mewborn hemolytic diseases
• jewborn hemolytic diseases
• hewborn hemolytic diseases
• nwwborn hemolytic diseases
• nswborn hemolytic diseases
• ndwborn hemolytic diseases
• nrwborn hemolytic diseases
• n4wborn hemolytic diseases
• n3wborn hemolytic diseases
• neqborn hemolytic diseases
• neaborn hemolytic diseases
• nesborn hemolytic diseases
• neeborn hemolytic diseases
• ne3born hemolytic diseases
• ne2born hemolytic diseases
• newvorn hemolytic diseases
• newnorn hemolytic diseases
• newhorn hemolytic diseases
• newgorn hemolytic diseases